Denali Therapeutics Inc (DNLI)
Operating Cash Flow Growth
-24.15%
TTM · Period ending:
DNLI Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-24.15%period ending
Latest reported-24.15%period ending
DNLI TTM Cash from Operations YoY % (-5.91% → -24.15%)
Year-over-year change
High-resolution chart · PNG
DNLI operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -24.1462% | |
| -12.8013% | |
| -18.6676% | |
| -9.6904% | |
| 10.5511% | |
| 11.4501% | |
| 2.8763% | |
| -9.2287% | |
| -29.5611% | |
| -78.3893% | |
| -46.2884% | |
| -39.7606% | |
| -35.9317% | |
| 0.7927% | |
| -15.7657% | |
| -164.5473% | |
| -154.1913% | |
| -155.4842% | |
| -150.7961% | |
| 353.0982% | |
| 332.7897% | |
| 339.2125% | |
| 374.5501% | |
| -1,252.8656% | |
| -1,062.3852% | |
| -1,174.9927% | |
| -402.4503% | |
| 82.4965% | |
| 68.7964% | |
| 43.1564% | |
| 165.3957% | |
| 19.9048% | |
| 36.205% | |
| 67.5881% | |
| -5.9094% |